Tearsheet

Innovative Eyewear (LUCY)


Market Price (12/4/2025): $1.37 | Market Cap: $4.4 Mil
Sector: Health Care | Industry: Health Care Equipment

Innovative Eyewear (LUCY)


Market Price (12/4/2025): $1.37
Market Cap: $4.4 Mil
Sector: Health Care
Industry: Health Care Equipment

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -131%
Weak multi-year price returns
2Y Excs Rtn is -134%, 3Y Excs Rtn is -166%
Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -8.0 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -405%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 29%
Meaningful short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 14%
Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -393%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -404%
2 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -53%
  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -118%
3 Megatrend and thematic drivers
Megatrends include Augmented Human & Smart Wearables. Themes include Smart Eyewear.
  High stock price volatility
Vol 12M is 162%
0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -131%
1 Strong revenue growth
Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is 29%
2 Valuation becoming less expensive
P/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -53%
3 Megatrend and thematic drivers
Megatrends include Augmented Human & Smart Wearables. Themes include Smart Eyewear.
4 Weak multi-year price returns
2Y Excs Rtn is -134%, 3Y Excs Rtn is -166%
5 Meaningful short interest
Short Interest % of Basic SharesShort Interest % of Basic Shares = (Short Interest Quantity) / (Basic Shares Outstanding). A high fraction of short interest can indicate potential risk of a short squeeze. is 14%
6 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -8.0 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -405%
7 Not cash flow generative
CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -393%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -404%
8 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -118%
9 High stock price volatility
Vol 12M is 162%

Valuation, Metrics & Events

LUCY Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback



1. LUCY's stock price experienced a significant decline of 75.88% in 2025. This indicates a strong bearish trend throughout the year leading up to the specified period. The stock closed at $1.40 on December 3, 2025.

2. Bearish technical signals and moving averages indicated a negative forecast for the stock. As of December 1, 2025, Innovative Eyewear Inc.'s overall moving average trend was bearish with four negative signals and no positive signals. Short-selling activity also suggested anticipated further declines.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
LUCY Return----69%-42%-73%-95%
Peers Return36%31%-16%2%14%4%81%
S&P 500 Return16%27%-19%24%23%16%112%

Monthly Win Rates [3]
LUCY Win Rate--50%25%33%20% 
Peers Win Rate57%65%45%57%60%50% 
S&P 500 Win Rate58%75%42%67%75%70% 

Max Drawdowns [4]
LUCY Max Drawdown----71%-61%-69% 
Peers Max Drawdown-26%-9%-42%-24%-19%-11% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: EW, MASI, UFPT, ATRC, ABT.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/3/2025 (YTD)

How Low Can It Go

Unique KeyEventLUCYS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-93.1%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven1357.9%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days

Compare to EW, MASI, UFPT, ATRC, ABT


In The Past

Innovative Eyewear's stock fell -93.1% during the 2022 Inflation Shock from a high on 8/15/2022. A -93.1% loss requires a 1357.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Innovative Eyewear (LUCY)

Better Bets than Innovative Eyewear (LUCY)

Latest Trefis Analyses

Title
0ARTICLES

Trade Ideas

Select past ideas related to LUCY. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
4.1%4.1%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-9.8%-9.8%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.0%6.0%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
9.7%9.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
6.2%6.2%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
4.1%4.1%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-9.8%-9.8%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
6.0%6.0%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
9.7%9.7%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
6.2%6.2%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Innovative Eyewear

Peers to compare with:

Financials

LUCYEWMASIUFPTATRCABTMedian
NameInnovati.Edwards .Masimo UFP Tech.AtriCure Abbott L. 
Mkt Price1.4083.98138.09219.6636.31125.29104.64
Mkt Cap0.049.17.51.71.7218.34.6
Rev LTM25,8842,18259851843,8431,390
Op Inc LTM-81,61913395-267,713114
FCF LTM-880016887166,917128
FCF 3Y Avg-76889356-95,96575
CFO LTM-81,01720899439,119154
CFO 3Y Avg-695514767188,132107

Growth & Margins

LUCYEWMASIUFPTATRCABTMedian
NameInnovati.Edwards .Masimo UFP Tech.AtriCure Abbott L. 
Rev Chg LTM29.3%10.6%38.5%29.5%15.8%6.4%22.6%
Rev Chg 3Y Avg58.7%4.4%11.4%23.4%18.0%-0.6%14.7%
Rev Chg Q87.6%14.7%8.2%6.5%15.8%6.9%11.4%
QoQ Delta Rev Chg LTM15.8%3.5%1.3%1.6%3.7%1.7%2.6%
Op Mgn LTM-404.9%27.5%6.1%16.0%-5.1%17.6%11.0%
Op Mgn 3Y Avg-686.0%28.9%8.9%15.8%-6.2%16.3%12.4%
QoQ Delta Op Mgn LTM52.6%-0.4%2.0%-0.6%1.7%0.2%0.9%
CFO/Rev LTM-392.8%17.3%9.5%16.6%8.3%20.8%13.1%
CFO/Rev 3Y Avg-586.4%18.7%8.1%13.5%3.6%19.5%10.8%
FCF/Rev LTM-403.6%13.6%7.7%14.6%3.1%15.8%10.6%
FCF/Rev 3Y Avg-612.5%13.4%5.3%11.2%-2.8%14.3%8.2%

Valuation

LUCYEWMASIUFPTATRCABTMedian
NameInnovati.Edwards .Masimo UFP Tech.AtriCure Abbott L. 
Mkt Cap0.049.17.51.71.7218.34.6
P/S3.47.73.72.63.35.33.5
P/EBIT-0.926.6-46.716.5-76.827.07.8
P/E-0.933.3-14.022.9-58.716.77.9
P/CFO-0.944.738.315.539.225.632.0
Total Yield-113.4%3.0%-7.1%4.4%-1.7%7.7%0.6%
Dividend Yield0.0%0.0%0.0%0.0%0.0%1.7%0.0%
FCF Yield 3Y Avg-79.5%1.6%1.1%3.5%-0.4%3.0%1.3%
D/E0.00.00.10.10.00.10.1
Net D/E-1.3-0.10.00.1-0.00.0-0.0

Returns

LUCYEWMASIUFPTATRCABTMedian
NameInnovati.Edwards .Masimo UFP Tech.AtriCure Abbott L. 
1M Rtn-18.1%1.1%-4.7%10.4%6.7%1.2%1.1%
3M Rtn-26.1%3.4%1.0%7.9%4.4%-4.8%2.2%
6M Rtn-54.8%7.9%-15.3%-8.5%4.0%-4.9%-6.7%
12M Rtn-79.7%19.6%-20.7%-26.6%0.5%9.8%-10.1%
3Y Rtn-94.2%9.7%-5.1%79.7%-20.3%22.9%2.3%
1M Excs Rtn-18.1%1.1%-4.7%10.4%6.7%1.2%1.2%
3M Excs Rtn-30.5%-1.6%-8.8%-0.2%-3.5%-10.6%-6.2%
6M Excs Rtn-69.6%-6.8%-30.0%-23.2%-10.7%-19.6%-21.4%
12M Excs Rtn-92.6%4.2%-33.5%-45.5%-13.1%-6.1%-23.3%
3Y Excs Rtn-166.4%-62.0%-75.5%15.5%-90.0%-46.8%-68.8%

Financials

Price Behavior

Short Interest

Short Interest: As Of Date11142025
Short Interest: Shares Quantity460,865
Short Interest: % Change Since 103120251128.7%
Average Daily Volume1,888,174
Days-to-Cover Short Interest1
Basic Shares Quantity3,214,790
Short % of Basic Shares14.3%

SEC Filings

Expand for More

Report DateFiling DateFiling
6302025814202510-Q 6/30/2025
3312025513202510-Q 3/31/2025
12312024324202510-K 12/31/2024
93020241112202410-Q 9/30/2024
6302024812202410-Q 6/30/2024
3312024514202410-Q 3/31/2024
12312023325202410-K 12/31/2023
93020231114202310-Q 9/30/2023
6302023811202310-Q 6/30/2023
3312023512202310-Q 3/31/2023
12312022324202310-K 12/31/2022
93020221110202210-Q 9/30/2022
6302022926202210-Q 6/30/2022
123120218162022424B4 12/31/2021
123120201262022S-1/A 12/31/2020